AFP and neoplasm: Specifically, AFP-L3% has been related to progression from moderately to poorly differentiated HCC and PIVKA II has been associated with tumor vascular invasion, whereas progressive levels of AFP have been associated with tumor systemic spread and poor patient outcomes [19-23].